Insulin resistance

Reference

• DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991: 14(3): 173–94
   PubMed Web of Science ®Google Scholar
• Bonadonna RC, Groop L, Kraemer N, et al. Obesity and insulin resistance in humans: a dose-response study. Metabolism 1990: 39(5): 452–9
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. Lilly Lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988: 37(6): 667–87
   Google Scholar
• Kahn BB, Cushman SW. Subcellular translocation of glucose transporters: role in insulin action and its perturbation in altered metabolic states. Diabetes Metab Rev 1985: 1(3): 203–27
   PubMedGoogle Scholar
• DeFronzo RA, Ferrannini E, Simonson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989: 38(4): 387–95
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Simonson DC, Katz LD, et al. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism 1988: 37(1): 79–85
   PubMed Web of Science ®Google Scholar
• Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979: 28(6): 688–705
   PubMed Web of Science ®Google Scholar
• Groop LC, Saloranta C, Shank M, et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991: 72(1): 96–107
   PubMed Web of Science ®Google Scholar
• Saloranta C, Franssila-Kallunki A, Ekstrand A, et al. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991: 34(6): 409–15
   PubMed Web of Science ®Google Scholar
• Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990: 13(6): 610–30
   PubMed Web of Science ®Google Scholar
• Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia 1985: 28(3): 119–21
   PubMed Web of Science ®Google Scholar
• Clark A, Wells CA, Buley ID, et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 1988: 9(4): 151–9
   PubMedGoogle Scholar
• O'Rahilly S, Turner RC, Matthews DR. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 1988: 318(19): 1225–30
   PubMed Web of Science ®Google Scholar
• Calles-Escandon J, Robbins DC. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes 1987: 36(10): 1167–72
   PubMed Web of Science ®Google Scholar
• Leahy JL. Natural history of beta-cell dysfunction in NIDDM. Diabetes Care 1990: 13(9): 992–1010
   PubMed Web of Science ®Google Scholar
• Unger RH. Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. Science 1991: 251 (4998): 1200–5
   PubMed Web of Science ®Google Scholar
• Kosaka K, Kuzuya T, Akanuma Y, et al. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 1980: 18(1): 23–8
   PubMed Web of Science ®Google Scholar
• Lillioja S, Mott DM, Howard BV, et al. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1988: 318(19): 1217–25
   PubMed Web of Science ®Google Scholar
• Warram JH, Martin BC, Krolewski AS, et al. Slow glucose removal rate and hyperinsu-linemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990: 113(12): 909–15
   PubMed Web of Science ®Google Scholar
• Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989;321(18): 1231–45 [erratum, N Engl J Med 1990: 322(1): 71]
   PubMed Web of Science ®Google Scholar
• McCurdy DK. Hyperosmolar hyperglycemic nonketotic diabetic coma. Med Clin North Am 1970: 54(3): 683–99
   PubMed Web of Science ®Google Scholar
• Shen DC, Shieh SM, Fuh MM, et al. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988: 66(3): 580–3
   PubMed Web of Science ®Google Scholar
• Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989: 320(11): 702–6
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981: 21(3): 165–71
   PubMed Web of Science ®Google Scholar
• Rowe JW, Young JB, Minaker KL, et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981: 30(3): 219–25
   PubMed Web of Science ®Google Scholar
• Pfeifle B, Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981: 20(2): 155–8
   PubMed Web of Science ®Google Scholar
• Rahmani-Jourdheuil D, Mourayre Y, Vague P, et al. In vivo insulin effect on ATPase activities in erythrocyte membrane from insulin-dependent diabetics. Diabetes 1987: 36(9): 991–5
   PubMed Web of Science ®Google Scholar
• O'Hare JA, Ferriss JB, Brady D, et al. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985: 7(6 Pt 2): 1143–8
   Google Scholar
• Resnick LM. Hypertension and abnormal glucose homeostasis: possible role of divalent ion metabolism. Am J Med 1989: 87(6A): 17–22S
   Web of Science ®Google Scholar
• Julius S, Gudbrandsson T, Jamerson K, et al. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991: 9(11): 983–6
   PubMed Web of Science ®Google Scholar
• Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking. Lancet 1992;339(8802): 1128–30 [erratum, Lancet 1992: 339(8807): 1492]
   PubMed Web of Science ®Google Scholar
• Sowers JR, Nyby M, Stern N, et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982: 4(5): 686–91
   PubMed Web of Science ®Google Scholar
• Krotkiewski M, Mandroukas K, Sjostrom L, et al. Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism 1979: 28(6): 650–8
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989: 321 (13): 868–73
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Selinus I, et al. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 1989: 298(6681): 1152–7
   PubMed Web of Science ®Google Scholar
• Dornhorst A, Powell SH, Pensky J. Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion. Lancet 1985: 1(8421): 123–6
   PubMed Web of Science ®Google Scholar
• Lithell HO, Pollare T, Berne C. Insulin sensitivity in newly detected hypertensive patients: influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters. J Cardiovasc Pharmacol 1990: 15(Suppl 5): S46–52
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Selinus I, et al. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988: 31(7): 415–20
   PubMed Web of Science ®Google Scholar
• Bell DS. Hypoglycemia induced by enalapril in patient with insulin resistance and NIDDM. (Letter) Diabetes Care 1992: 15(7): 934–6
   PubMed Web of Science ®Google Scholar
• Pollare T, Lithell H, Morlin C, et al. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989: 7(7): 551–9
   PubMed Web of Science ®Google Scholar
• Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 1991: 14(Suppl 4): 39–47
   PubMed Web of Science ®Google Scholar
• Tobey TA, Greenfield M, Kraemer F, et al. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in nor-motriglyceridemic man. Metabolism 1981: 30(2): 165–71
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Levy RI. Pathogenesis and management of lipoprotein disorders. N Engl J Med 1985: 312(20): 1300–10
   PubMed Web of Science ®Google Scholar
• Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990: 10(2): 223–31
   PubMedGoogle Scholar
• Kobayashi M, Shigeta Y, Hirata Y, et al. Improvement of glucose tolerance in NIDDM by Clofibrate: randomized double-blind study. Diabetes Care 1988: 11(6): 495–9
   PubMed Web of Science ®Google Scholar
• Bell DS, Wagenknecht LE. Effect of gemfibrozil on intermediate-density lipoproteins in NIDDM patients: a retrospective study. (Letter) Diabetes Care 1992: 15(1): 146–7
   PubMed Web of Science ®Google Scholar
• Garg A, Grundy SM. Gemfibrozil alone and in combination with lovastatin for treatment of hypertriglyceridemia in NIDDM. Diabetes 1989: 38(3): 364–72 [erratum, Diabetes 1990: 39(10): 1313]
   PubMed Web of Science ®Google Scholar
• Fuller JH, Shipley MJ, Rose G, et al. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1980: 1 (8183): 1373–6
   PubMed Web of Science ®Google Scholar
• Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, ten years later. Horm Metab Res (Suppl) 1985: 15: 41–6
   PubMed Web of Science ®Google Scholar
• Capron L, Jarnet J, Kazandjian S, et al. Growth-promoting effects of diabetes and insulin on arteries: an in vivo study of rat aorta. Diabetes 1986: 35(9): 973–8
   PubMed Web of Science ®Google Scholar
• Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985: 291(6488): 97–104
   PubMed Web of Science ®Google Scholar
• MacMahon S, Cutler JA, Stamler J. Antihypertensive drug treatment: potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension 1989: 13(5 Suppl): 145–50
   PubMedGoogle Scholar
• Naeye RL. Infants of diabetic mothers: a quantitative morphologic study. Pediatrics 1965: 35(Jun): 980–8
   PubMedGoogle Scholar
• Geffner ME, Golde DW. Selective insulin action on skin, ovary, and heart in insulin-resistant states. Diabetes Care 1988: 11 (6): 500–5
   PubMed Web of Science ®Google Scholar
• Frohlich ED, Sasaki O. Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol 1990: 16(6): 1492–9
   PubMed Web of Science ®Google Scholar
• Messerli FH, Soria F. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death. Am J Med 1992: 93(2A): 21–6S
   Web of Science ®Google Scholar